7
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Severe hypercalcemia in a patient with pulmonary tuberculosis

      letter

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Dear Editor, Hypercalcemia is a common metabolic abnormality in tuberculosis. It is usually mild and asymptomatic. We report a patient presenting with severe hypercalcemia and renal failure secondary to pulmonary tuberculosis. Presenting a 41 year old daily labourer presented with the complaints of being unwell for a year. He also complained of low-grade fever, chronic productive cough, loss of appetite, and weight loss of 20 kg during the same time. Two months before the presentation, he had developed extreme tiredness and fatiguability and on evaluation was found to be anemic requiring two units of packed red cell transfusions elsewhere. On general examination, he was emaciated, dehydrated, and pale. His vitals were normal except a temperature of 100.2 F. Chest examination revealed bronchial breath sounds in the right infraclavicular and mammary regions with generalized hollowing of the supraclavicular and infraclavicular region suggesting a fibrocavitary lesion in the right upper lobe. Rest of the systemic examination was unremarkable. On admission, his blood investigations revealed hemoglobin of 5.3 mg/dl (mean curpuscular volme: 61.4 fL, reticulocyte: 0.80%), total white cell count of 5400 with 83% neutrophil, 9% lymphocytes, 8% monocytes, and platelets 4.27 lakh. Biochemical investigations revealed a serum calcium of 14.2 (is it 14.2 or 14.6) (8.3–10.4 mg/dl), phosphate of 2.5 (2.5–4.6 mg/dl), parathyroid hormone of 11.7 (8.0–74 pg/ml), alkaline phosphatase of 87 (40–125 U/L), serum creatinine of 2.55 mg%, and serum urea 68 mg/dl. The urine 24 h measured 4980 ml with a 24 h urinary calcium of 408 mg/24 h (<240 mg/24 h). Blood urea nitrogen/creatinine ratio was 9.55 suggesting an intrinsic renal pathology. Urine analysis was normal. Chest radiograph revealed a fibrocavitary lesion involving the right and left upper lobe [Figure 1]. On ultrasonography of abdomen, kidneys were of normal shape and volume with no evidence of nephrocalcinosis or nephrolithiasis. 3 sets of sputum smears were positive for acid-fast bacilli (1+, 3+, 1+), a diagnosis of pulmonary tuberculosis was established, and the patient was initiated on appropriate antitubercular therapy based on culture susceptibility. Evaluation of hypercalcemia was suggestive of a parathyroid independent mechanism of hypercalcemia. He also had an elevated Vitamin D. Hence, the cause of the hypercalcemia was attributed to extra-renal 1-alpha hydroxylase activity in the alveolar macrophages. Figure 1 Posterior anterior chest X-ray showing the right upper lobe fibrocavitatory lesion and left upper lobe fibrosis Parathyroid independent hypercalcemia can occur in patients with disseminated malignancy, multiple myeloma, and other granulomatous disorders. Hypercalcemia with new onset renal failure could also be explained by paraproteinemias. In our patient, serum electrophoresis, urine bence jones protein, skeletal survey, and bone marrow did not show any evidence to suggest paraproteinemias. In view of his microcytic and hypochromic anemia with an elevated red cell distribution width, a disseminated malignancy or lymphoproliferative disorder could also have presented with such severe hypercalcemia. However, our patient's tumor marker levels, malignancy workup including a bone marrow were normal. As hypercalcemia is well documented with granulomatous disorders, it was hence attributed to tuberculosis. He was initiated on weight-based antitubercular therapy for pulmonary tuberculosis. With vigorous saline hydration and diuresis with frusemide, there was a serial decline in the serum calcium [Figure 2] in the subsequent 10 days. There was also a serial decline in the serum creatinine. Figure 2 Decrease in calcium during hospitalization with pulmonary tuberculosis and acute kidney injury He was discharged in a stable condition following the management of acute severe hypercalcemia, and is on follow-up for completion of antitubercular therapy. He was advised to avoid excessive sun exposure, decrease oral Vitamin D, or calcium supplements and to avoid milk products. Hyperparathyroidism and malignancy account for 80–90% of cases of hypercalcemia.[1] The first step in the evaluation of a patient with hypercalcemia is to assess whether it is parathyroid dependent or independent. A normal or low parathyroid hormone level would mean a parathyroid independent pathology. Various causes which needs to be considered are parathyroid hormone related peptide (PTHrP) mediated hypercalcemia, activation of extra-renal 1-alpha hydroxylase, osteolytic bone metastasis, and Vitamin D intoxication.[2] Hypercalcemia is known to occur in granulomatous disease most commonly sarcoidosis and tuberculosis.[3 4] The incidence of hypercalcemia in tuberculosis varies from 2% to 25% depending on the geographical area where the study was conducted and is depended on multiple other factors such as the intake of calcium, Vitamin D, and exposure to the sun.[5 6 7 8 9] In a study carried out in Jabalpur Military Hospital, in 94 patients with active tuberculosis, only 5 had hypercalcemia.[10] Mechanism of hypercalcemia in tuberculosis is considered to be due to the extra-renal production of 1,25(OH)2D3 by alveolar macrophages and T lymphocytes possibly CD8 T lymphocytes.[11] However, hypercalcemia independent of the following mechanism is also reported. Activated Vitamin D plays an important role in the regulation of granulomatous inflammation and influences the cell-mediated immunity to tuberculosis. If produced in large quantities, there may be spillage into the systemic circulation causing severe hypercalemia.[12] Our patient also had absorptive hypercalciuria further substantiating the presence of increased activated Vitamin D in the circulation.[13] In the incidence studies mentioned above, it was found that patients with granulomatous disorders and hypercalcemia were from areas where there was increased calcium and Vitamin D consumption in their daily diet.[5 6 7 8 9] Our patient, a daily laborer also was a gentleman who used to work in the sun, which could explain the elevated circulating activated Vitamin D causing severe hypercalcemia. Our patient also had renal failure at presentation which could be one of the presentations of hypercalcemia. Renal complications of hypercalcemia will depend on the degree and duration of hypercalcemia. Severe hypercalcemia of 12–15 mg/dl can cause acute renal failure by direct renal vasoconstriction and volume contraction causing a decrease in glomerular filtration rate.[13] Longstanding hypercalcemia can lead to chronic hypercalciuria causing nephrolithiasis.[13 14] In our patient, renal functions started to improve with hydration and starting of antitubercular therapy, but it did not normalize till the last follow-up. The presence of hypercalemia in patients with pyrexia of unknown origin requires meticulous evaluation for tuberculosis.[14] Conclusion Severe hypercalcemia can be a manifestation of pulmonary tuberculosis even though its rare. Hypercalcemia in pulmonary tuberculosis is due to excessive extra-renal 1-alpha hydroxylase activity, and hence, limiting oral Vitamin D and calcium supplements is one of the major interventions in the treatment of hypercalcemia due to tuberculosis. Among tuberculosis patients presenting with renal failure hypercalcemia must be looked for and managed promptly. Financial support and sponsorship Nil. Conflicts of interest There are no conflicts of interest.

          Related collections

          Most cited references14

          • Record: found
          • Abstract: found
          • Article: not found

          Differential diagnosis of hypercalcemia.

          F Lafferty (1991)
          The differential diagnosis of hypercalcemia has expanded to over 25 separate disease states, with primary hyperparathyroidism and malignancy accounting for 80-90% of all hypercalcemic patients. Primary hyperparathyroidism comprises the majority of hypercalcemic patients among the ambulatory population, but malignancy accounts for up to 65% of such patients in the hospital. Factors favoring primary hyperparathyroidism include a family history of hyperparathyroidism or multiple endocrine neoplasia, a history of childhood radiation to the head and neck, the postmenopausal state, a history of renal calculi or peptic ulcer, hypertension, the induction of hypercalcemia by thiazides, or an asymptomatic patient with a prolonged, stable mild hypercalcemia. The usefulness of the serum calcium, parathyroid hormone, chloride, phosphorus, serum 25-OHD, and 1,25-(OH)2D, and urinary calcium in the differential diagnosis of hypercalcemia is discussed. The pitfalls of an excessive reliance on the serum PTH in diagnosing hyperparathyroidism are stressed. The discriminant values of the serum calcium, chloride, phosphorus, and parathyroid hormone are explored, with the serum parathyroid hormone, chloride, and calcium proving most useful in separating primary hyperparathyroidism from other forms of hypercalcemia. Multivariate discriminant analysis using the serum calcium, phosphorus, and chloride and the hematocrit achieves an accuracy of 95-98% and is the most economical method of identifying hyperparathyroidism. The addition of the amino-terminal or intact PTH assay increases the accuracy to 99% and is essential in the presence of renal insufficiency.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            1,25(OH)2D2 production by T lymphocytes and alveolar macrophages recovered by lavage from normocalcemic patients with tuberculosis.

            To compare extra-renal 1,25(OH)2D3 production in different types of granulomatous disease, and to identify the cell types responsible, we have evaluated the conversion of 25(OH)D3 in 1,25(OH)2D3 by uncultured cells recovered by bronchoalveolar lavage and blood mononuclear cells from normocalcemic patients with sarcoidosis and tuberculosis. 1,25(OH)2D3 was produced both by lavage cells (12/12 tuberculosis patients, 2/6 sarcoidosis patients) and blood mononuclear cells (3/5 tuberculosis patients, 0/3 sarcoidosis patients) from patients but not controls, but significantly greater amounts were produced by lavage cells from tuberculosis patients than those of sarcoidosis patients (P less than 0.001). 1,25(OH)2D3 production by lavage cells from tuberculosis patients correlated with the number of CD8+ T lymphocytes present but not other cell types. T lymphocytes appeared to be an important source of 1,25(OH)2D3 production, since purified T lymphocytes from all patients with tuberculosis produced 1,25(OH)2D3, and 1,25(OH)2D3 production by these cells correlated closely with that produced by unseparated lavage cells. Because 1,25(OH)2D3 can improve the capacity of macrophages to kill mycobacteria, our results support the conclusion that macrophage-lymphocyte interactions, mediated at least in part by 1,25(OH)2D3, may be an important component of a successful antituberculous immune response.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Hypercalcemic crisis.

              T Ziegler (2001)
              Hypercalcemia may decompensate from a more or less chronic status into a critical and life-threatening condition, hypercalcemic crisis. In the majority of cases, primary hyperparathyroidism is the cause; humoral hypercalcemia of malignancy or rarer conditions of hypercalcemia will decompensate less often. The leading symptoms that characterize the crisis are oliguria and anuria as well as somnolence and coma. After a hypercalcemic crisis is recognized, an emergency diagnostic program has to be followed either to prove or to exclude primary hyperparathyroidism. In the first case, surgical neck exploration is the only way to avoid fatal outcome. The diagnostic program should be performed within hours; during this time, serum calcium should be lowered. Treatment of choice is hemodialysis against a calcium-free dialysate. Bisphosphonates could be useful as adjuvant drugs.
                Bookmark

                Author and article information

                Journal
                J Family Med Prim Care
                J Family Med Prim Care
                JFMPC
                Journal of Family Medicine and Primary Care
                Medknow Publications & Media Pvt Ltd (India )
                2249-4863
                2278-7135
                Apr-Jun 2016
                : 5
                : 2
                : 509-511
                Affiliations
                [1 ] Department of Medicine, Christian Medical College, Vellore, Tamil Nadu, India
                Author notes
                Address for correspondence: Dr. Akhil Rajendra, Department of Medicine, Christian Medical College, Vellore - 632 002, Tamil Nadu, India. E-mail: akhilrk1989@ 123456gmail.com
                Article
                JFMPC-5-509
                10.4103/2249-4863.192327
                5084602
                27843882
                07f18027-3f36-4d06-8a59-addb03ec761c
                Copyright: © Journal of Family Medicine and Primary Care

                This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.

                History
                Categories
                Letter to Editor

                Comments

                Comment on this article